Literature DB >> 13106496

Tubercle bacilli resistant to isoniazid; virulence and response to treatment with isoniazid in guinea-pigs.

D A MITCHISON.   

Abstract

Entities:  

Keywords:  MYCOBACTERIUM TUBERCULOSIS/effect of drugs on; NICOTINIC ACID ISOMERS/effects

Mesh：

Substances：

Year:  1954        PMID： 13106496      PMCID： PMC2084405          DOI： 10.1136/bmj.1.4854.128

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  1 in total

1.  Isoniazid in the control of experimental corneal tuberculosis.

Authors:  R GOULDING; J M ROBSON
Journal:  Lancet       Date:  1952-11-01       Impact factor: 79.321
  1 in total
  13 in total

1.  The course of pulmonary tuberculosis in patients excreting organisms which have acquired resistance. Response to continued treatment for a second year with isoniazid alone or with isoniazid plus PAS.

Authors:  C V RAMAKRISHNAN; A L BHATIA; S DEVADATTA; W FOX; A S NARAYANA; J B SELKON; S VELU
Journal:  Bull World Health Organ       Date:  1962       Impact factor: 9.408

2.  Bacterial resistance to isoniazid and marsilid in treatment of pulmonary tuberculosis; results of trials.

Authors:  C M OGILVIE
Journal:  Br Med J       Date:  1954-10-09

3.  The role of the host in the chemotherapy of tuberculosis.

Authors:  P D HART
Journal:  Br Med J       Date:  1954-10-02

Review 4.  The emergence of extensively drug-resistant tuberculosis: a global health crisis requiring new interventions: part I: the origins and nature of the problem.

Authors:  Jerrold J Ellner
Journal:  Clin Transl Sci       Date:  2008-12       Impact factor: 4.689

Review 5.  Virulence versus resistance.

Authors:  K M Krasinski
Journal:  Bull N Y Acad Med       Date:  1987-04

6.  Physiological cost of rifampin resistance induced in vitro in Mycobacterium tuberculosis.

Authors:  O J Billington; T D McHugh; S H Gillespie
Journal:  Antimicrob Agents Chemother       Date:  1999-08       Impact factor: 5.191

Review 7.  Strain diversity, epistasis and the evolution of drug resistance in Mycobacterium tuberculosis.

Authors:  S Borrell; S Gagneux
Journal:  Clin Microbiol Infect       Date:  2011-06       Impact factor: 8.067

8.  Antimicrobial therapy of pulmonary tuberculosis.

Authors:  W McDermott
Journal:  Bull World Health Organ       Date:  1960       Impact factor: 9.408

9.  Treatment as prevention and other interventions to reduce transmission of multidrug-resistant tuberculosis.

Authors:  R R Nathavitharana; P Lederer; D B Tierney; E Nardell
Journal:  Int J Tuberc Lung Dis       Date:  2019-04-01       Impact factor: 2.373

10.  The impact of mouse passaging of Mycobacterium tuberculosis strains prior to virulence testing in the mouse and guinea pig aerosol models.

Authors:  Paul J Converse; Kathleen D Eisenach; Sue A Theus; Eric L Nuermberger; Sandeep Tyagi; Lan H Ly; Deborah E Geiman; Haidan Guo; Scott T Nolan; Nicole C Akar; Lee G Klinkenberg; Radhika Gupta; Shichun Lun; Petros C Karakousis; Gyanu Lamichhane; David N McMurray; Jacques H Grosset; William R Bishai
Journal:  PLoS One       Date:  2010-04-21       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.